Atlas Trials

A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

Clinical trial NCT06819826 · RECRUITING

Trial details

NCT number
NCT06819826
Sponsor
Biocity Biopharmaceutics Co., Ltd.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
IgA Nephropathy (IgAN)
Start date
2025-02-14
Primary completion
2026-12-31
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.